Formerly IMI International Medical Innovations. PreMD Inc., a predictive medicine company, empowers patients and physicians alike with simple, non-invasive tests that detect early-stage cardiovascular disease and cancer. Our mission is to prevent life-threatening illnesses and promote long-term health and wellness.
This test non-invasively measures cholesterol in the skin tissues to assess risk of heart disease.
This minimally invasive, painless test for colorectal cancer, currently in development, has several advantages over FOBT.